Windtree Therapeutics (WINT) has released an update to notify the public and investors about the unregistered sales of equity securities.
The content detailed in Item 1.01 of the Current Report has been incorporated for reference into Item 3.02, ensuring that the information is fully integrated and accessible within the report.
For further insights into WINT stock, check out TipRanks’ Stock Analysis page.
